Irish Biopharm Firm Gets Orphan Drug Designation From FDA

Dublin biopharmaceutical company Genable Technologies has been granted orphan drug designation from the Federal Drug Administration (FDA) in the US for its gene therapy product GT308 that it is developing to treat the eye disease retinitis pigmentosa.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Authors: Source Type: news